跳至主要内容
临床试验/CTRI/2022/02/039994
CTRI/2022/02/039994进行中(未招募)2 期

A clinical study to assess the efficacy of a treatment module including Shodhana followed by Shamana in the management of Benign Prostatic Hyperplasia (Mutraghata)

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients diagnosed with BPH Grade I, II or III.
  • 2. Patients having classical signs and symptoms of Mutraghata.
  • 3. Patients fit for Anulomana and Uttara Basti.

排除标准

  • 1. Age below 40 years or above 80 years
  • 2. Patients diagnosed with BPH Grade IV
  • 3. Patients with malignancy, congenital deformities of urogenital tract or any pathology other than BPH
  • 4. Patients with Diabetes Mellitus, Hypertension, Renal disorders or any other systemic disease
  • 5. Patients unfit for Anulomana and Uttara Basti

研究者

相似试验